CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464097528
- Phone
- 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $89,088
- in 5 filings, $89K under 10b5-1 plans
Net −$89,088. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 4 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-11-20 | Hack Andrew A. F. Chief Financial Officer | Sale | −5,000 | $25.35 | $127K | 0 |
| 2017-11-20 | Hack Andrew A. F. Chief Financial Officer | Option exercise · Stock Option (right to buy) | −5,000 | 145,076 | ||
| 2017-11-17 | Hack Andrew A. F. Chief Financial Officer | Option exercise | +5,000 | $3.23 | $16K | 5,000 |
| 2017-11-17 | Hack Andrew A. F. Chief Financial Officer | Sale | −5,000 | $24.81 | $124K | 0 |
| 2017-11-17 | Hack Andrew A. F. Chief Financial Officer | Option exercise · Stock Option (right to buy) | −5,000 | 150,076 | ||
| 2017-11-01 | Bosley Katrine President and CEO | Sale | −6,108 | $23.37 | $143K | 1,393,322 |
| 2017-11-01 | Bosley Katrine President and CEO | Sale | −1,925 | $24.25 | $47K | 1,391,397 |
| 2017-11-01 | Bosley Katrine President and CEO | Sale | −300 | $25.05 | $8K | 1,391,097 |
| 2017-10-02 | Bosley Katrine President and CEO | Sale | −8,133 | $24.77 | $201K | 1,399,630 |
| 2017-10-02 | Bosley Katrine President and CEO | Sale | −200 | $25.33 | $5K | 1,399,430 |
| 2017-09-05 | Bosley Katrine President and CEO | Sale | −6,666 | $20.20 | $135K | 1,407,763 |
| 2017-09-01 | Bosley Katrine President and CEO | Sale | −9,800 | $20.40 | $200K | 1,414,629 |
| 2017-09-01 | Bosley Katrine President and CEO | Sale | −200 | $21.20 | $4K | 1,414,429 |
| 2017-08-17 | Cole Douglas G. Director | Other acquisition | +1,686 | 3,171 | ||
| 2017-08-11 | Bosley Katrine President and CEO | Sale | −6,666 | $20.02 | $133K | 1,424,429 |
| 2017-08-10 | Bosley Katrine President and CEO | Sale | −10,000 | $20.02 | $200K | 1,431,095 |
| 2017-06-15 | Bitterman Kevin Director | Grant or award · Stock Option (right to buy) | +11,538 | 11,538 | ||
| 2017-06-15 | Cole Douglas G. Director | Grant or award · Stock Option (right to buy) | +11,538 | 11,538 | ||
| 2017-06-15 | MENDLEIN JOHN Director | Grant or award · Stock Option (right to buy) | +11,538 | 11,538 | ||
| 2017-06-15 | Nikolic Boris Director | Grant or award · Stock Option (right to buy) | +11,538 | 11,538 |
Page 23 of 30 · 588 trades